<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39311433</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1941-2479</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>23</Day></PubDate></JournalIssue><Title>Asia-Pacific journal of public health</Title><ISOAbbreviation>Asia Pac J Public Health</ISOAbbreviation></Journal><ArticleTitle>Predictors for COVID-19-Specific and Non-COVID-19-Specific Deaths: A Cohort Study in Taiwan.</ArticleTitle><Pagination><StartPage>10105395241282634</StartPage><MedlinePgn>10105395241282634</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/10105395241282634</ELocationID><Abstract><AbstractText>Predictors for coronavirus disease 2019 (COVID-19)-specific and non-COVID-19-specific deaths have not been extensively studied. This cohort study in Taiwan investigated predictors for COVID-19-specific and non-COVID-19-specific deaths among hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. From January to July 2022, 2196 COVID-19 patients at Taipei City Hospital were consecutively recruited in this cohort study. Among the 175 deceased COVID-19 patients, 147 (84.0%) and 28 (16.0%) had COVID-19-specific and non-COVID-19-specific deaths, respectively. After controlling for other covariates, multinomial logistic regressions showed that age â‰¥ 65 was significantly associated with higher risks for both COVID-19-specific, adjusted odds ratio (AOR) = 6.21; 95% confidence interval (CI) [3.12, 12.35]; and non-COVID-19-specific deaths (AOR = 6.06; 95% CI [1.34, 27.34]). Fully vaccinated individuals (AOR = 0.50; 95% CI [0.33, 0.74]) and Paxlovid recipients (AOR = 0.45; 95% CI [0.20, 0.98]) had lower COVID-19-specific death risks, while comorbid cancer or end-stage renal disease patients faced higher risks of non-COVID-19-specific deaths. Our study findings suggest that vaccination and Paxlovid treatment are crucial for reducing SARS-CoV-2-specific mortalities, while comorbid patients need careful monitoring to reduce non-COVID-19-specific deaths.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Shang-Yih</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Taipei City Hospital-Heping Fuyou Branch, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Care Management, National Taipei University of Nursing and Health Sciences, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Taipei, Taipei.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Hsin-Hao</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Section of Infectious Diseases, Taipei City Hospital-Yangming Branch, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, National Yang Ming Chiao Tung University, Taipei.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lai</LastName><ForeName>Yun-Ju</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Health Care Management, National Taipei University of Nursing and Health Sciences, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, National Yang Ming Chiao Tung University, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Puli Branch, Taichung Veterans General Hospital, Puli.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Exercise Health Science, National Taiwan University of Sport, Taichung.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chao-Ming</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>University of Taipei, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Taipei City Hospital, Taipei.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chu-Chieh</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Health Care Management, National Taipei University of Nursing and Health Sciences, Taipei.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Shen-Shong</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>School of Medicine, National Yang Ming Chiao Tung University, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Gastroenterology, Taipei City Hospital-Yang-Ming Branch, Taipei City.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Public Health, National Yang Ming Chiao Tung University, Taipei.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yen</LastName><ForeName>Yung-Feng</ForeName><Initials>YF</Initials><Identifier Source="ORCID">0000-0002-4469-4732</Identifier><AffiliationInfo><Affiliation>Department of Health Care Management, National Taipei University of Nursing and Health Sciences, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Taipei, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Public Health, National Yang Ming Chiao Tung University, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Infectious Diseases, Taipei City Hospital-Heping Fuyou Branch, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Education and Research, Taipei City Hospital, Taipei.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chiu</LastName><ForeName>Yi-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Division of Urology, Department of Surgery, Taipei City Hospital, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, College of Medicine and Shu-Tien Urological Research Center, National Yang Ming Chiao Tung University, Taipei.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Exercise and Health Sciences, University of Taipei, Taipei.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Asia Pac J Public Health</MedlineTA><NlmUniqueID>8708538</NlmUniqueID><ISSNLinking>1010-5395</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Taiwan</Keyword><Keyword MajorTopicYN="N">cohort study</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword></KeywordList><CoiStatement>Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>23</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39311433</ArticleId><ArticleId IdType="doi">10.1177/10105395241282634</ArticleId></ArticleIdList></PubmedData></PubmedArticle>